Whitbread board opposes Corvex director appointment proposal

Whitbread PLC has released an investor presentation challenging a proposal from Corvex Management LP to add a new director to the company's board, according to a press release. The presentation was made ahead of a shareholder meeting set for November 9, 2026, to be held at Whitbread Court in Dunstable, Bedfordshire. Whitbread's board unanimously advised investors to vote against Corvex's resolution to appoint James Gemmel as a director.

The board's opposition is based on three primary reasons: their faith in the current five-year strategic plan, early advancements in executing that plan, and the breadth of experience held by the existing board. The company disclosed that it conducted a strategic review with the assistance of Goldman Sachs, J.P. Morgan Cazenove, and Morgan Stanley.

Whitbread's half-year performance for the fiscal year 2027 (H1 FY27) demonstrated early strides in implementing the strategic plan. The board argued that Corvex had not offered an alternative to the five-year plan nor demonstrated how Gemmel's addition would improve plan execution or augment board abilities. Additionally, the board voiced concern that Gemmel's appointment might cause disruption during plan implementation.

All directors intend to cast their personal shares in opposition to the resolution. Further information is available in a shareholder circular published on October 13, 2026. The investor presentation is accessible on Whitbread's website at www.whitbread.co.uk. This report was generated with AI assistance and subsequently reviewed by an editor.